Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and ...
Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...
Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...
The Chosun Ilbo on MSN
Dried blood samples match CSF accuracy in Alzheimer's detection
A technology that diagnoses various diseases, including Alzheimer’s and Parkinson’s, using just a few drops of blood from a ...
Long before memory problems appear, your brain may already be losing neurons. That is the unsettling message from new work by ...
The government’s new vision for dementia diagnosis is ambitious: by 2029, more than 92 per cent of patients could receive a diagnosis within 18 weeks of referral, up from fewer than half today. Backed ...
HOUSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical ...
Trial design and comparator group - FDA and Plus discussed a randomized controlled trial design approach and that the study may include an intrathecal chemotherapeutic as a comparator, as well as ...
Artificial intelligence can use brain recordings from a single night in a sleep lab to predict a person's risk of developing ...
Plasma measures of phosphorylated tau217 (p-tau217) can accurately identify individuals in the preclinical stage of Alzheimer’s disease (AD), a new meta-analysis showed. The results are important ...
A new cellular balance test can detect a hidden inflammation in the brain, helping physicians to spot multiple sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback